Mitral valve prolapse syndrome: Orthostatic hypotension and physiopathology of its clinical symptomatholgies;Mitral kapak prolapsusu sendromu: Ortostatik hipotansiyon ve klinik semptomlarinin fizyopatolojisi

Anadolu Kardiyoloji Dergisi

Volumn 3, Issue 1, 2003, Pages 60-64

  Dursunoǧlu, Dursun ^a   Evrengül, Harun ^a   Semiz, Ender ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADRENERGIC ACTIVITY; ANXIETY; AUTONOMIC DYSFUNCTION; BLOOD VOLUME; CHOLINERGIC SYSTEM; CLINICAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FATIGUE; HEART ARRHYTHMIA; HEART PALPITATION; HORMONE RELEASE; HUMAN; MITRAL VALVE PROLAPSE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PRESSORECEPTOR; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYMPTOMATOLOGY; SYNCOPE; TACHYCARDIA; THORAX PAIN; VERTIGO;

DIZZINESS; HUMANS; HYPOTENSION, ORTHOSTATIC; MITRAL VALVE PROLAPSE; SYNCOPE; SYNDROME;

EID: 0037232805     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Boudoulas H, Kolibash AJ Jr, Baker P. Mitral valve prolapse and mitral valve prolapse syndrome: a diagnostic classification and pathogenesis of symptoms. Am Heart J, 1989; 118: 796-818.
2. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcomes of mitral valve prolapse. N Engl J Med 1999; 341: 1-7.
3. Nishimura R, McGoon MD. Perspectives on mitral valve prolapse. N Engl J Med 1999; 341: 48-58.
4. Devereux RB, Jones EC, Roman MJ, et al. Prevalence and correlates of mitral valve prolapse in population-based sample of American Indians: the Strong Heart study. Am J Med 2001 Dec 15; 111: 679-85.
5. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in general population. 1. Epidemiologic features: The Framingham Study. Am Heart J, 1983; 106:571-6.
6. Levy D, Savage DD. Prevalence and clinical features of mitral valve prolapse. Am Heart J, 1987; 113:1281-90.
7. Devereux RB. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995; 10:107-16.
8. O'Rourke RA. The Syndrome of Mitral Valve Prolapse. In: Albert JA, editor. Valvular Heart Disease. NY: Lippincott-Raven; 1999: p.157-182.
9. Boudoulas H, Woodley CF. Pathogenesis of symptoms in mitral valve prolapse syndrome. In Boudoulas H, Wooley CF, editors. Mitral Valve Prolapse and the Mitral Valve Prolapse Syndrome. Mt. Kisco, NY: Futura Publishing Company. Inc; 1988. p. 479-510.
10. Devedreux RB, Kramer-Fox R, Kligfled P. Mitral valve prolapse: causes, clinical manifestations and management. Ann Intern Med 1989;111.305-17.
11. Pini R, Roman MJ, Kramer-Fox R, Devereux RB. Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Circulation 1989; 80:915-24.
12. Giesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic centinuum. JAMA, 1989; 262:523-32.
13. Crawford MH, O'Rourke RA. Mitral valve prolapse: a cardiomyopathic state? Prog Cardiovasc Dis 1984;27: 133-9.
14. Ansari A. Syndrome of mitral valve prolapse: current perspectives. Prog Cardiovasc Dis 1989; 32:31-72.
15. Tamura K, Fukuda Y, Yamanka N, Ferrans VJ. Structural abnormalities of connective tissue in floppy mitral valve (abstract). J Am Coll Cardiol 1994; 23: 32A.
16. Gaffney AF, Bastian BC, Lane LB, et al. Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol 1983; 52: 316-20.
17. Crawford MH. Mitral valve prolapse due to coronary artery disease. Am J Med 1977;62:447-51.
18. Tamura K, Fuduka Y, Yamanka N, Ferrans VJ. Structural abnormalities of connective tissue in floppy mitral valve (abstract). J Am Coll Cardiol 1994;23;32A.
19. King BD, Clark MA, Baba N, Kilman JW, Wooley JF. Myxomatous mitral valves: collagen dissolution as the primary defect. Circulation 1982; 66:288-96.
20. Baker PB, Bansal G, Boudoulas H, Kolibash AJ, Kilman J, Wooley CF. Floppy mitral valve chordae tendinae: histopathological alterations. Hum Pathol 1988; 19: 507-12.
21. Shrivastava S, Guthrie RB, Edwards JE. Prolapse of the mitral valve. Mod Concepts Cardiovasc Dis 1977; 46: 57-61.
22. Bashore TM, Grines C, Utlak D, Boudoulas H, Wooley CF. Postural exercise abnormalities in symptomatic patients with mitral valve prolapse. J Am Coll Cardiol 1988; 11: 499-507.
23. Boudoulas H, Wooley CF. Hyperadrenergic state, autonomic dysfunction and pathogenesis of symptoms in mitral valve prolapse syndrome. In: Boudoulas H, Wooley CF, editors. Mitral Valve Prolapse and the Mitral Valve Prolapse Syndrome. Mount Kisco, NY: Futura Publishing Company, Inc; 1988: p.479-10.
24. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Metabolic studies in mitral valve prolapse syndrome. Circulation 1980; 61: 1200-5.
25. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Mitral valve prolapse syndrome: the effect of adrenergic stimulation. J Am Coll Cardiol 1983; 2: 638-44.
26. Rogers JM, Boudoulas H, Wooley CF. Abnormal renin-aldosterone response to volume depletion in mitral valve prolapse (Abstract). Circulation 1984; 70: (Suppl II): 336.
27. Boudoulas H, Wooley CF. Mitral Valve Prolapse Syndrome: therapeutic considerations. In: Boudoulas H, Wooley CF, editors. Mitral Valve Prolapse and the Mitral Valve Prolapse Syndrome. Mount Kisco, NY: Futura Publishing Company, Inc; 1988. p. 555-63.
28. Pasternac A, Tubern JF, Puddu PE, Kral RB, Champlain J. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med 1982; 73: 783-90.
29. Pasternac A, Latour JG, Leger-Gauthier C, Lambert M, Cantin M, de Champlain J. Stability of hyperadrenergic state, atrial natriuretic factor and platelet abnormalities in mitral valve prolapse syndrome. In Boudoulas H, Wooley CF, editors. The Mitral Valve Prolapse and the Mitral Valve Prolapse Syndrome. Mount Kisco, NY: Futura Publishing Company, Inc; 1988. p.455-63.
30. Rogers JM, Boudoulas H, Malarkay WB, Wooley CF. Mitral valve prolapse: disordered catecholamine regulation with intravascular volume maneuvers (Abstract). Circulation 1983; 68 (Suppl III). 310.
31. Boudoulas H, Lewis RP, Kates RE, Dalmangas G. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subject. Ann Intern Med 1977; 87: 433-6.
32. Davies AO, Mares A, Pool JL, Taylor AA. Mitral valve prolapse with symptoms of beta adrenergic hypersensitivity. Beta2 adrenergic receptor supercoupling with desensitization of isoproterenol exposure. Am J Med 1987; 82: 193-201.
33. Gaffney AF, Karlsson ES, Campbell W, et al. Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation 1979; 59: 894-901.
34. Gaffney AF, Blomqvist GC. Mitral valve prolapse and autonomic nervous system dysfunction: a pathophysiological link. In: Boudoulas H, Wooley CF, editors. Mitral Valve Prolapse and the Mitral Valve Prolapse Syndrome. Mount Kisco, NY: Futura Publishing Company. Inc; 1988: p.427-43.
35. Fontana ME, Wooley CF, Leighton RF, Lewis RP. Postural changes in left ventricular and mitral valvular dynamics in the systolic click-late systolic murmur syndrome. Circulation 1975; 51: 167-73.
36. Santos AD, Mathew PK, Hilal A, Wallace WA. Orthostatic hypotension: a commonly unrecognized cause of symptoms in mitral valve prolapse. Am J Med 1981; 71: 746-50.
37. Devereux RB, Latas EM, Brown WT, Kramer-Fox R, Laragh JH. Association of mitral valve prolapse with low body weight and low blood pressure. Lancet 1982; 2: 792-5.
38. Coghlan HC, Phares P, Cowley M, Copley D, James TN. Dysautonomia in mitral valve prolapse. Am J Med 1979; 67: 236-44.
39. De Carvalho JGR, Messerli FH, Frohlich ED. Mitral valve prolapse and borderline hypertension. Hypertension 1979; 1: 518-22.
40. Natarajan G, Nakhjavan FK, Kahn D. Myocardial metabolic studies in prolapsing mitral leaflet syndrome. Circulation 1975; 52: 1105-10.
41. Boudoulas H, Cobb TC, Leighton RF, Wilt SM. Myocardial lactate production in patients with angina like chest pain and angiographically normal coronary arteries. Am J Cardiol 1974; 34: 501-5.
42. Lewinter MM, Hoffman JR, Shell WE, Karliner JS, O'Rourke RA. Phenilephrine induced atypical chest pain in patients with prolapsing mitral valve leaflets. Am J Cardiol 1974; 34: 12-8.
43. Nutter DO, Wickliffe C, Gilbert CA, Moody C, King SB II. The pathophysiology of idiopathic mitral valve prolapse. Circulation 1975; 52: 297-305.
44. Robertson D, Shannon JR, Biaggioni I, et al. Orthostatic intolerance and the postural tachycardia syndrome: genetic and environment pathophysiologies. Neurolab Autonomic Team Pflugers Arch 2000; 441 (2-3 Suppl): R 48-51.
45. Abinader EG, Shahar J. Exercise testing in mitral valve prolapse before and after beta blockade. Br Heart J 1982; 48: 130-3.
46. Engel PJ, Alpert BL, Hickman JR. The nature and prevalence of the abnormal exercise electrocardiogram in mitral valve prolapse. Am Heart J 1979; 98: 716-24.
47. Massie BE, Botvinick EH, Shames D, et al. Myocardial perfusion scintigraphy in patients with mitral valve prolapse. Its advantage over stress electrocardiography in diagnosing of associated coronary artery disease and its implications for the etiology of chest pain. Circulation 1978; 57: 19-26.